Discontinued — last reported Q4 '15
Corvex Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value increased by 266.6% to $6.47 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 266.6%, from $1.76 to $6.47. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate significant reversals of compensation expense, which can impact net income positively.
The weighted average grant-date fair value of equity instruments, excluding options, that were forfeited during the peri...
Standard disclosure for companies with significant stock-based compensation plans.
other_share_based_compensation_arrangement_by_share_base_add435| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $1.77 | $1.77 | $1.77 | $1.77 | $6.47 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +266.6% |
| YoY Change | — | — | — | — | +266.6% |